Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gitte M Knudsen

Showing results (211-220 of 342) with videos related to

Pageof 35
Sort By:
Neuroimage|May 16, 2012
5-HTTLPR status predictive of neocortical 5-HT4 binding assessed with [(11)C]SB207145 PET in humansPatrick M Fisher, Klaus K Holst, Brenda Mc Mahon, et al.
Cephalalgia : an International Journal of Headache|July 22, 2017
Low 5-HT<sub>1B</sub> receptor binding in the migraine brain: A PET studyMarie Deen, Hanne D Hansen, Anders Hougaard, et al.
Journal of Affective Disorders|January 13, 2018
Amygdala response to emotional faces in seasonal affective disorderCamilla Borgsted, Brice Ozenne, Brenda Mc Mahon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 9, 2024
Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic researchFriederike Holze, Martin K Madsen, Claus Svarer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 6, 2018
Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter - A longitudinal combined <sup>11</sup>C-DASB and <sup>11</sup>C-SB207145 PET studyBrenda Mc Mahon, Martin Nørgaard, Claus Svarer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2013
Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRIChristin Y Sander, Jacob M Hooker, Ciprian Catana, et al.
Frontiers in Nuclear Medicine|October 11, 2024
The Alzheimer's disease 5xFAD mouse model is best suited to investigate pretargeted imaging approaches beyond the blood-brain barrierSara Lopes van den Broek, Dag Sehlin, Jens V Andersen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2013
Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodiesMorten Ziebell, Birgitte B Andersen, Lars H Pinborg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 21, 2023
EEG abnormalities are not associated with poor antidepressant treatment outcome - A NeuroPharm studyKristian H Reveles Jensen, Olalla Urdanibia-Centelles, Vibeke H Dam, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Cocaine is pharmacologically active in the nonhuman primate fetal brainHelene Benveniste, Joanna S Fowler, William D Rooney, et al.
Pageof 35

Showing results (211-220 of 342) with videos related to

Sort By:
Pageof 35
Neuroimage|May 16, 2012
5-HTTLPR status predictive of neocortical 5-HT4 binding assessed with [(11)C]SB207145 PET in humansPatrick M Fisher, Klaus K Holst, Brenda Mc Mahon, et al.
Cephalalgia : an International Journal of Headache|July 22, 2017
Low 5-HT<sub>1B</sub> receptor binding in the migraine brain: A PET studyMarie Deen, Hanne D Hansen, Anders Hougaard, et al.
Journal of Affective Disorders|January 13, 2018
Amygdala response to emotional faces in seasonal affective disorderCamilla Borgsted, Brice Ozenne, Brenda Mc Mahon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 9, 2024
Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic researchFriederike Holze, Martin K Madsen, Claus Svarer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 6, 2018
Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter - A longitudinal combined <sup>11</sup>C-DASB and <sup>11</sup>C-SB207145 PET studyBrenda Mc Mahon, Martin Nørgaard, Claus Svarer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2013
Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRIChristin Y Sander, Jacob M Hooker, Ciprian Catana, et al.
Frontiers in Nuclear Medicine|October 11, 2024
The Alzheimer's disease 5xFAD mouse model is best suited to investigate pretargeted imaging approaches beyond the blood-brain barrierSara Lopes van den Broek, Dag Sehlin, Jens V Andersen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2013
Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodiesMorten Ziebell, Birgitte B Andersen, Lars H Pinborg, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 21, 2023
EEG abnormalities are not associated with poor antidepressant treatment outcome - A NeuroPharm studyKristian H Reveles Jensen, Olalla Urdanibia-Centelles, Vibeke H Dam, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Cocaine is pharmacologically active in the nonhuman primate fetal brainHelene Benveniste, Joanna S Fowler, William D Rooney, et al.
Pageof 35